ArticleSocial psychiatry and psychiatric epidemiology2025
Epidemiology of adult separation anxiety disorder in the Kingdom of Saudi Arabia: results from the Saudi National Mental Health Survey.
Article in Social psychiatry and psychiatric epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAdult separation anxiety disorder (ASAD) is thought to be prevalent and debilitating, yet many aspects of its epidemiology remain unclear. We aimed to investigate prevalence, course, correlates, comorbidity, impairment, and treatment of ASAD in Saudi Arabia.
methodsThe study analyzed a subset of 1793 participants from the Saudi National Mental Health Survey; a nationally representative household sample of Saudi citizens. The survey used the CIDI 3.0 to produce prevalence estimates of ASAD and other common DSM-IV mental disorders. Cross tabulations, survival analysis and logistic regression were used to analyse the data.
resultsThe lifetime and 12-month prevalence of ASAD were 7.6% and 3.8%, respectively. Over half (51.7%) of participants with lifetime ASAD had onset in adulthood, and 50.5% of those with lifetime ASAD also had 12-month ASAD. Lifetime ASAD was significantly associated with being female (OR = 2.1), not being married (ORs = 2.2-3.2), having low education (OR = 0.4), and maladaptive family functioning (ORs = 3.6-6.7). Primary lifetime ASAD was a strong predictor of subsequent other mental disorders (ORs = 1.1-6.5). Further, mood, impulse, and substance use disorders were significantly associated with subsequent first onset of ASAD (ORs = 2.15-3.0). ASAD was severely impairing in the presence (59.0%) or absence (56.2%) of 12-month comorbidity. Among those with lifetime ASAD, only 26.1% reported treatment for a mental health condition.
conclusionASAD is prevalent, with a persistent course and associated impairment, as well as substantial comorbidity and limited treatment in Saudi Arabia. Increasing awareness, early diagnosis, and treatment of ASAD may help reduce its burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.